Safeguard Scientifics, Inc. (SFE) financial statements (2022 and earlier)
Company profile
| Business Address |
150 NORTH RADNOR-CHESTER ROAD RADNOR, PA 19087 |
| State of Incorp. | PA |
| Fiscal Year End | December 31 |
| SIC | 6799 - Investors, Not Elsewhere Classified (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 16 | 25 | 46 | 25 | 30 | 64 | 137 | ||
| Cash and cash equivalents | 16 | 25 | 8 | 21 | 22 | 33 | 112 | ||
| Short-term investments | 38 | 8 | 8 | 31 | 25 | ||||
| Other undisclosed cash, cash equivalents, and short-term investments | 0 | (4) | |||||||
| Restricted cash and investments | 0 | 1 | |||||||
| Other undisclosed current assets | 0 | 1 | 3 | 8 | 2 | 6 | 2 | ||
| Total current assets: | 16 | 26 | 49 | 34 | 33 | 70 | 139 | ||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 2 | 2 | 1 | 2 | 2 | 2 | 0 | ||
| Long-term investments and receivables | 50 | 77 | 96 | 135 | 191 | 184 | 177 | ||
| Long-term investments | 50 | 77 | 96 | 135 | 191 | 181 | 174 | ||
| Accounts and financing receivable, after allowance for credit loss | 3 | 4 | |||||||
| Restricted cash and investments | 6 | 6 | |||||||
| Other noncurrent assets | 1 | 2 | 1 | 0 | 0 | 2 | 2 | ||
| Total noncurrent assets: | 53 | 81 | 97 | 143 | 199 | 188 | 180 | ||
| TOTAL ASSETS: | 69 | 108 | 146 | 176 | 232 | 258 | 318 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 3 | 2 | 6 | 5 | 6 | 6 | 7 | ||
| Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Accrued liabilities | 0 | 1 | 2 | 2 | 2 | 3 | 2 | ||
| Employee-related liabilities | 3 | 1 | 3 | 3 | 3 | 3 | 4 | ||
| Debt | 0 | 22 | 40 | ||||||
| Other undisclosed current liabilities | 0 | 5 | |||||||
| Total current liabilities: | 3 | 2 | 33 | 46 | 6 | 6 | 7 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 2 | 2 | 43 | 45 | 53 | 52 | 51 | ||
| Long-term debt, excluding current maturities | 43 | 45 | 53 | 52 | 51 | ||||
| Operating lease, liability | 2 | 2 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Liabilities, other than long-term debt | 1 | 1 | 3 | 4 | 4 | 4 | 4 | ||
| Other liabilities | 1 | 1 | 3 | 4 | 4 | 4 | 4 | ||
| Total noncurrent liabilities: | 3 | 3 | 46 | 49 | 56 | 56 | 54 | ||
| Total liabilities: | 6 | 6 | 79 | 95 | 62 | 62 | 61 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent | 63 | 102 | 67 | 82 | 170 | 196 | 258 | ||
| Common stock | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||
| Treasury stock, value | (10) | (14) | (15) | (17) | (21) | (20) | (19) | ||
| Additional paid in capital | 808 | 811 | 811 | 813 | 816 | 817 | 820 | ||
| Accumulated other comprehensive loss | (0) | (0) | (0) | (0) | (0) | (0) | |||
| Accumulated deficit | (737) | (697) | (731) | (715) | (627) | (604) | (545) | ||
| Other undisclosed stockholders' equity | 0 | ||||||||
| Total stockholders' equity: | 63 | 102 | 67 | 82 | 170 | 196 | 258 | ||
| TOTAL LIABILITIES AND EQUITY: | 69 | 108 | 146 | 176 | 232 | 258 | 318 | ||
Income statement (P&L) ($ in millions)
| 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Other income | 0 | 0 | ✕ | |||||
| Gross profit: | 0 | 0 | ||||||
| Operating expenses | (9) | (10) | (17) | (17) | (19) | (18) | (19) | |
| Other undisclosed operating income (loss) | 0 | (0) | (0) | |||||
| Operating loss: | (9) | (10) | (17) | (17) | (19) | (18) | (19) | |
| Nonoperating income (expense) | (7) | 14 | (2) | 4 | 0 | 2 | 34 | |
| Investment income, nonoperating | 0 | 2 | 3 | 4 | 2 | 2 | 2 | |
| Other nonoperating income (expense) | (8) | 12 | (5) | (0) | (2) | 0 | 32 | |
| Interest and debt expense | (14) | (16) | (9) | (5) | (5) | (4) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | (17) | (10) | (35) | (22) | (23) | (20) | 10 | |
| Income (loss) from equity method investments | (21) | 64 | 20 | (66) | 1 | (40) | (15) | |
| Net income (loss) available to common stockholders, diluted: | (38) | 55 | (16) | (89) | (22) | (60) | (5) | |
Comprehensive Income ($ in millions)
| 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (38) | 55 | (16) | (89) | (22) | (60) | (5) | |
| Other comprehensive income (loss) | (0) | (16) | (88) | (22) | (60) | 0 | ||
| Comprehensive income (loss): | (38) | 55 | (31) | (177) | (45) | (119) | (5) | |
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (0) | |||||||
| Comprehensive income (loss), net of tax, attributable to parent: | (38) | 55 | (31) | (177) | (45) | (119) | (5) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.